1-4 of 4
dexpramipexole
Close
Sort by
Journal Articles

Panch SR, Bozik ME, Brown T, et al. Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes. Blood. 2018;132(5):501-509.

Journal: Blood
Blood (2018) 132 (13): 1461.
https://doi.org/10.1182/blood-2018-08-870204
Published: 2018
Journal Articles

Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes

Clinical Trials & Observations
Sandhya R. Panch, Michael E. Bozik, Thomas Brown, Michelle Makiya, Calman Prussin, Donald G. Archibald, Gregory T. Hebrank, Mary Sullivan, Xiaoping Sun, Lauren Wetzler, JeanAnne Ware, Michael P. Fay, Cynthia E. Dunbar, Steven I. Dworetzky, Paneez Khoury, Irina Maric, Amy D. Klion
Journal: Blood
Blood (2018) 132 (5): 501–509.
https://doi.org/10.1182/blood-2018-02-835330
Published: 2018
Includes: Supplemental data
Journal Articles

Dexpramipexole: a new antieosinophil drug?

Clinical Trials & Observations
Gerald J. Gleich
Journal: Blood
Blood (2018) 132 (5): 461–462.
https://doi.org/10.1182/blood-2018-06-851600
Published: 2018
Journal Articles

Dexpramipexole As a Steroid-Sparing Agent in Hypereosinophilic Syndromes (HES): An Open-Label Proof-of-Concept Study

Sandhya R. Panch, MD MPH, Michael Bozik, MD, Thomas Brown, RN, Ulrike Demarco, Dipl. Biol., Jamie Hahn, BS, Alexander Komarov, PhD, Tamika Magee, RN, Michelle Makiya, RN, Calman Prussin, MD, Armando Signore, PhD, Mary Sullivan, BA, Lauren Wetzler, MHS, PA, Cynthia E. Dunbar, MD, Steven Dworetzky, PhD, Irina Maric, MD, Amy D Klion, MD
Journal: Blood
Blood (2016) 128 (22): 1327.
https://doi.org/10.1182/blood.V128.22.1327.1327
Published: 2016